化合物庫
CUDC-101
CUDC-101;7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide;7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide;CUDC 101;CUDC101,CUDC-101;UNII-1A7Y9MP123;7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide;Heptanamide, 7-[[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxy;7-[[4-[(3-Ethynylphenyl)aMino]-7-Methoxy-6-quinazolinyl]oxy]-N-hydroxyheptanaMide;HeptanaMide, 7-[[4-[(3-ethynylphenyl)aMino]-7-Methoxy-6-quinazolinyl]oxy]-N-hydroxy-;7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide CUDC-101;CUDC101;1A7Y9MP123;AK174946;7-((4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide;7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide;7-((4-((3-ethynylp;DB12174;CCG-264856;HY-10223;NCGC00263177-12;SB19287;BCP9000556;SMR004701272;AKOS022526176;EX-A842;J-000340;FT-0665231;SW219934-1;NCGC00263177-05;NCGC00263177-01;BCP01935;AS-16955;NS00072541;J-519062;MFCD15528940;1012054-59-9;7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide;Q27076925;MLS006010163;GTPL8894;s1194;NSC-800081;CHEMBL598797;CUDC-101, Free Base;1313875-12-5;HMS3654C20;SCHEMBL93769;NSC800081;CUDC 101 [WHO-DD];BDBM50307768;compound 8 [PMID: 20143778];DTXSID00143784;AC-28428;CUDC-101, >=98%;7-(4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl)oxy-N-hydroxyheptanamide;compound 8 (PMID: 20143778);BRD-K41278234-001-03-0;DTXCID7066275;HDAC/EGFR/HER2 Inhibitor CUDC-101;CUDC-101?
C9851
C24H26N4O4
4-甲氧基-5,6,7,8-四氫萘-1-磺酰氯;7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羥基庚酰胺;CUDC-101 抑制劑
434.49
Cudc-101
訂購此產(chǎn)品
-
訂購、服務(wù)熱線：028-82632533
-
| 中文名稱： | CUDC-101 | ||
|---|---|---|---|
| 英文名稱: | CUDC-101;7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide;7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide;CUDC 101;CUDC101,CUDC-101;UNII-1A7Y9MP123;7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide;Heptanamide, 7-[[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxy;7-[[4-[(3-Ethynylphenyl)aMino]-7-Methoxy-6-quinazolinyl]oxy]-N-hydroxyheptanaMide;HeptanaMide, 7-[[4-[(3-ethynylphenyl)aMino]-7-Methoxy-6-quinazolinyl]oxy]-N-hydroxy-;7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide CUDC-101;CUDC101;1A7Y9MP123;AK174946;7-((4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide;7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide;7-((4-((3-ethynylp;DB12174;CCG-264856;HY-10223;NCGC00263177-12;SB19287;BCP9000556;SMR004701272;AKOS022526176;EX-A842;J-000340;FT-0665231;SW219934-1;NCGC00263177-05;NCGC00263177-01;BCP01935;AS-16955;NS00072541;J-519062;MFCD15528940;1012054-59-9;7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide;Q27076925;MLS006010163;GTPL8894;s1194;NSC-800081;CHEMBL598797;CUDC-101, Free Base;1313875-12-5;HMS3654C20;SCHEMBL93769;NSC800081;CUDC 101 [WHO-DD];BDBM50307768;compound 8 [PMID: 20143778];DTXSID00143784;AC-28428;CUDC-101, >=98%;7-(4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl)oxy-N-hydroxyheptanamide;compound 8 (PMID: 20143778);BRD-K41278234-001-03-0;DTXCID7066275;HDAC/EGFR/HER2 Inhibitor CUDC-101;CUDC-101? | ||
| 中文別名： | 4-甲氧基-5,6,7,8-四氫萘-1-磺酰氯;7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羥基庚酰胺;CUDC-101 抑制劑 | ||
| 英文別名： | Cudc-101 | ||
| 產(chǎn)品編輯： | C9851 | ||
| CAS號： | 1012054-59-9 | 長期儲(chǔ)存條件： | |
| 分子式： | C24H26N4O4 | 純度： | |
| 分子量： | 434.49 | 檢測方式： | |
| 結(jié)構(gòu)類型： | 產(chǎn)品運(yùn)輸貨期： | ||
| 植物來源： | 產(chǎn)品包裝： | ||
搜索質(zhì)檢報(bào)告(COA)
暫無下載信息
*半夏(3157321941)*
